GSA CAPITAL PARTNERS LLP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2022$361,000
-55.5%
639,937
-11.6%
0.05%
-50.5%
Q1 2022$811,000
-20.2%
724,202
+4.0%
0.11%
-14.8%
Q4 2021$1,016,000
-27.5%
696,115
+48.9%
0.13%
-10.5%
Q3 2021$1,402,000
+46.8%
467,371
+127.0%
0.14%
+33.6%
Q2 2021$955,000
+809.5%
205,882
+576.4%
0.11%
+494.4%
Q3 2020$105,00030,4390.02%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders